Vantage MedTech is growing and they’re planting new roots right here in Olathe. The medical technology company with global ambitions has found a new home to the suddenly resurgent Karbank Real Estate Company park off of 118th St. at the northwest corner of 119th Street and Renner Boulevard.
Vantage MedTech, an advanced medical device company with manufacturing capabilities, recently relocated its operations into the new Olathe facility, consolidating engineering, development and manufacturing teams under one roof as they position themselves for significant short-term and long-term growth.
“We are pleased and excited about our transition to the new facility in Olathe for three reasons,” Vantage MedTech Relocation Project Manager Rick Lacelock said. “It consolidates three previous facilities into one which greatly improves functional collaboration. There are more facility amenities which improve culture and morale, and finally it provides additional space for our growth over the next decade. We’d like to thank Karbank Real Estate and Jonkman Construction for quickly and efficiently adapting this great facility for our use.”
The move marks an important milestone for a burgeoning company, but making an impact in the industry. Formed through the merger of RBC Medical Innovations and Sterling Medical Devices in February 2023, Vantage MedTech now partners with both emerging startups and some of the world’s largest medical device companies to help bring complex electromechanical medical technologies from concept to commercialization.
“We’re still a smaller company in a lot of ways,” said Erik Hilliard, Senior Vice President of Business Development. “We run a lean enterprise. But the goal is growth, and this facility gives us the ability to do that.”
That growth potential was one of the biggest drivers behind the relocation to Olathe and a larger footprint. Previously in three separate Kansas facilities, Vantage’s engineering teams and manufacturing operations are now integrated into a single streamlined environment. The new space allows the company to move seamlessly from early-stage design and prototyping into manufacturing and assembly — a critical advantage in the industry.
“This office has full capabilities, from engineering through all the manufacturing,” Hilliard said. “The potential is here to grow this place even more than it is right now. That’s the goal.”
Vantage MedTech specializes in benchtop-based diagnostic and therapeutic devices.. Many of the technologies the company supports focus on highly targeted treatments, including cardiac ablation systems used to treat arrhythmias and other advanced therapeutic devices designed to improve patient outcomes through minimally invasive approaches.
The company’s work often begins in the earliest stages of product development, helping clients determine whether emerging concepts are clinically viable before advancing toward animal trials, human-ready devices and ultimately commercial production.
Their proprietary “Advantage Platforms” help accelerate development timelines by giving clients a faster starting point for testing and validation. Hilliard explained that this capability gives the company a meaningful competitive edge in a rapidly evolving market.
From a manufacturing perspective, Vantage currently focuses on high-value, lower-volume systems. The company assembles sophisticated capital equipment, with some devices valued at approximately $25,000 per unit. Looking ahead, leadership sees opportunities to expand into smaller, higher-volume products that could dramatically increase manufacturing output and market reach.
“What I’d love to see us grow into is more of what we have today, but with some smaller devices that have more volume to them,” Hilliard said. “It opens us up for more growth.”
Today, there are approximately 150 employees, companywide, with its New Jersey office focused primarily on design and engineering. The Olathe facility, however, serves as the organization’s operational hub — combining engineering expertise, manufacturing capabilities and future expansion potential in one location.
Company leadership believes the timing for that growth aligns well with the broader momentum building across Olathe’s innovation and business landscape. Under CEO Carlo Colasante, who previously led a successful MedTech company exit before joining Vantage, the organization is pursuing an ambitious strategy of doubling in size over the next four years both organically and through acquisitions.
For Olathe, the addition of a company like Vantage MedTech further strengthens the city’s growing reputation as a hub for advanced industries, technology and life sciences. Located along one of the community’s rapidly developing office parks, the company’s investment represents another example of how Olathe continues attracting innovative businesses that blend cutting-edge technology with high-skilled employment opportunities.
As Vantage MedTech continues expanding its capabilities and client partnerships, company leaders see Olathe playing a central role in shaping the next chapter of growth for the company itself and quite possibly the future of medical innovation.